Glenmark Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹3,275.68Cr |
Net Profits | ₹340.27Cr |
Net Profit Margins | 10.39% |
Highlights
Revenue:
Glenmark Pharmaceuticals Ltd’s revenue jumped 7.2% since last year same period to ₹3,275.68Cr in the Q1 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -15.15% fall in its revenue since last 3-months.
Net Profits:
Glenmark Pharmaceuticals Ltd’s net profit jumped 126.95% since last year same period to ₹340.27Cr in the Q1 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 127.93% jump in its net profits since last 3-months.
Net Profit Margins:
Glenmark Pharmaceuticals Ltd’s net profit margin jumped 111.72% since last year same period to 10.39% in the Q1 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 132.92% jump in its net profit margins since last 3-months.
